Demand For Biotech IPOs Cooling

 

The high demand for health-care IPOs may be starting to cool off after the number and volume of deals hit a new 12-year high earlier this year. After a strong start to the year, health-care IPOs hit some market resistance last month as several companies postponed plans to go public, an analysis showed last week. Despite this recent cool down, IPOs are still up more than 25 percent so far year to date.

 

Read more >>>

Bloomberg BRIEF Newsletters